Statistics for Metastatic Breast Cancer
Statistics can be frightening… and some statistics may not even apply to you and your specific type of cancer and your particular response to treatment.
Many statistics represent an average number. Not everyone falls into that average.
You are a statistic of one.
(O’Shaughnessy J. Extending Survival With Chemotherapy in Metastatic Breast Cancer The Oncologist.2005;10 (suppl 3): 20-9)
(American Cancer Society - 2008 Statistics)
(American Cancer Society 2011-2012 Annual report)
During 2004-2008, the median age at the time of breast cancer diagnosis was 61 years. This means that 50% of women who develop breast cancer were 61 years of age or younger at time of diagnosis
(American Society of Clinical Oncology [ASCO] Report - 2008)
(American Cancer Society statistics 2000 - 2011)
Danny Welch, PhD, a researcher on metastasis at University of Kansas Cancer Center (previously at University of Alabama) says only a few hundred scientists in the world are trying to understand the process: “It’s responsible for 90 percent of the morbidity and mortality, but gets less than 5 percent of the budget.” click here. see page 4. Quote is based on European studies and appeared originally in the Journal of European Cancer.
Metastatic Research Funding by Susan G. Komen Foundation
2012 ad campaign SGK states: “In just the past six years, over $35 million in funding has been awarded to help interrogate why cancer spreads, discover which genes can suppress tumor growth, develop therapeutics to target metastasis and find ways to help the immune system fight metastasis.
Using the Komen Audited Financial reports MBCN calculated the total Public Support & Revenue raised for the same last 6 year period which totalled: $2,012,000,000 or about $2 Billlion dollars. 36 million for metastatic research as a % of the total revenue raised = 1.7% (round up to 2%) In other words, $200 goes to metastatic research for every $10,000 raised by SGK.
click on the links below:
The Hope, The Hype, and Gap Between Reality & Perception (understanding "med-speak")